FIELD: medicine, oncology, pharmacy. SUBSTANCE: binding agent: conjugate of the general formula: [A-O-W-Z]a-T where T - carrier fragment; A-O-W is a residue of therapeutically acceptable anthracycline; Z - spacer group. Conjugate is synthesized by condensation of compound of the formula A-O-W-OH or its activated derivative with a substance (or their mixture) that is a spacer group Z, and with carrier fragment T. Condensation can be carried out in the presence of condensing agent. T - T-cellular antibodies, antibodies raised against CD5, transferrin receptors and others. Invention claims the compound of the formula A-O-W-[piperazine]-H that can be used for conjugate preparing. Invention can be used for treatment of some tumors in mammalian. EFFECT: improved therapeutic effect of drugs, decreased toxic effect after administration into body. 13 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
CONJUGATES OF ANTHRACYCLINE, METHOD FOR THEIR PRODUCTION AND USING | 1992 |
|
RU2107690C1 |
DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149163C1 |
BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTHRACYCLINE GLYCOSIDES BOUND WITH POLYMERIC DERIVATIVE | 1992 |
|
RU2118171C1 |
ANTHRACYCLINE GLYCOSIDE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2118328C1 |
POLYMERIC CONJUGATE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149646C1 |
AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
ANTHRACYCLINE GLYCOSIDES AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, METHOD OF THEIR SYNTHESIS, DIIODOINTERMEDIATE COMPOUND AND METHOD OF ITS SYNTHESIS | 1991 |
|
RU2100366C1 |
ANTHRACYCLIN DERIVATIVES | 1995 |
|
RU2159619C2 |
DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
Authors
Dates
1998-07-27—Published
1991-08-01—Filed